Recent studies have demonstrated that differentiation-inducing agents could modulate the responsiveness of cancer cells to IFN-α by regulating the expression of signal transducers and activators of transcription (STAT) proteins, a group of transcription factors which play important roles in the IFN signalling pathway. The gene discussed is SOAT1; the disease is cancer.